A microRNA expression ratio defining the invasive phenotype in bladder tumors

Abstract Objective The goal of this study was to identify a microRNA (miRNA) signature in bladder cancer capable of differentiating superficial from invasive disease. Methods Expression profiling of 343 miRNAs was performed in a microarray format using noninvasive and invasive bladder carcinoma cell...

Full description

Saved in:
Bibliographic Details
Published inUrologic oncology Vol. 28; no. 1; pp. 39 - 48
Main Authors Neely, Lori A., Ph.D, Rieger-Christ, Kimberly M., Ph.D, Neto, Brasil Silva, M.D, Eroshkin, Alexey, Ph.D, Garver, Joanne, B.S, Patel, Sonal, B.S, Phung, Nu Ai, B.S, McLaughlin, Stephen, Ph.D, Libertino, John A., M.D, Whitney, Duncan, Ph.D, Summerhayes, Ian C., Ph.D
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 2010
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract Objective The goal of this study was to identify a microRNA (miRNA) signature in bladder cancer capable of differentiating superficial from invasive disease. Methods Expression profiling of 343 miRNAs was performed in a microarray format using noninvasive and invasive bladder carcinoma cell lines with differential expression confirmed using a single molecule detection platform assay. miR-21 and miR-205 expression levels were determined in 53 bladder tumors (28 superficial and 25 invasive). Sensitivity, specificity, and a ROC curve were calculated to determine the discriminatory power of the miRNA ratio to predict invasion. Knockdown and forced expression of miRNAs was performed to evaluate their role in invasion. Results Expression profiling of 343 miRNAs, using noninvasive and invasive bladder cell lines, revealed significant differential expression of 9 miRNAs. Cell lines characterized as invasive showed a miR-21:miR-205 ratio at least 10-fold higher than the quantitative ratio obtained from non-invasive cell lines. The same expression ratio was determined in 53 bladder tumors. From these results, we recorded a sensitivity and specificity of 100% and 78%, respectively, using a cutoff of 1.79 to predict an invasive lesion. The area under the receiver operator characteristic curve was 0.89. Using in vitro invasion assays, we have demonstrated a role for miR-21 in establishing the invasive phenotype of bladder carcinoma cells. Conclusion In this study, we identified a miR-21:miR-205 expression ratio that has the ability to distinguish between invasive and noninvasive bladder tumors with high sensitivity and specificity, with the potential to identify superficial lesions at high risk to progress.
AbstractList Abstract Objective The goal of this study was to identify a microRNA (miRNA) signature in bladder cancer capable of differentiating superficial from invasive disease. Methods Expression profiling of 343 miRNAs was performed in a microarray format using noninvasive and invasive bladder carcinoma cell lines with differential expression confirmed using a single molecule detection platform assay. miR-21 and miR-205 expression levels were determined in 53 bladder tumors (28 superficial and 25 invasive). Sensitivity, specificity, and a ROC curve were calculated to determine the discriminatory power of the miRNA ratio to predict invasion. Knockdown and forced expression of miRNAs was performed to evaluate their role in invasion. Results Expression profiling of 343 miRNAs, using noninvasive and invasive bladder cell lines, revealed significant differential expression of 9 miRNAs. Cell lines characterized as invasive showed a miR-21:miR-205 ratio at least 10-fold higher than the quantitative ratio obtained from non-invasive cell lines. The same expression ratio was determined in 53 bladder tumors. From these results, we recorded a sensitivity and specificity of 100% and 78%, respectively, using a cutoff of 1.79 to predict an invasive lesion. The area under the receiver operator characteristic curve was 0.89. Using in vitro invasion assays, we have demonstrated a role for miR-21 in establishing the invasive phenotype of bladder carcinoma cells. Conclusion In this study, we identified a miR-21:miR-205 expression ratio that has the ability to distinguish between invasive and noninvasive bladder tumors with high sensitivity and specificity, with the potential to identify superficial lesions at high risk to progress.
The goal of this study was to identify a microRNA (miRNA) signature in bladder cancer capable of differentiating superficial from invasive disease. Expression profiling of 343 miRNAs was performed in a microarray format using noninvasive and invasive bladder carcinoma cell lines with differential expression confirmed using a single molecule detection platform assay. miR-21 and miR-205 expression levels were determined in 53 bladder tumors (28 superficial and 25 invasive). Sensitivity, specificity, and a ROC curve were calculated to determine the discriminatory power of the miRNA ratio to predict invasion. Knockdown and forced expression of miRNAs was performed to evaluate their role in invasion. Expression profiling of 343 miRNAs, using noninvasive and invasive bladder cell lines, revealed significant differential expression of 9 miRNAs. Cell lines characterized as invasive showed a miR-21:miR-205 ratio at least 10-fold higher than the quantitative ratio obtained from non-invasive cell lines. The same expression ratio was determined in 53 bladder tumors. From these results, we recorded a sensitivity and specificity of 100% and 78%, respectively, using a cutoff of 1.79 to predict an invasive lesion. The area under the receiver operator characteristic curve was 0.89. Using in vitro invasion assays, we have demonstrated a role for miR-21 in establishing the invasive phenotype of bladder carcinoma cells. In this study, we identified a miR-21:miR-205 expression ratio that has the ability to distinguish between invasive and noninvasive bladder tumors with high sensitivity and specificity, with the potential to identify superficial lesions at high risk to progress.
OBJECTIVEThe goal of this study was to identify a microRNA (miRNA) signature in bladder cancer capable of differentiating superficial from invasive disease.METHODSExpression profiling of 343 miRNAs was performed in a microarray format using noninvasive and invasive bladder carcinoma cell lines with differential expression confirmed using a single molecule detection platform assay. miR-21 and miR-205 expression levels were determined in 53 bladder tumors (28 superficial and 25 invasive). Sensitivity, specificity, and a ROC curve were calculated to determine the discriminatory power of the miRNA ratio to predict invasion. Knockdown and forced expression of miRNAs was performed to evaluate their role in invasion.RESULTSExpression profiling of 343 miRNAs, using noninvasive and invasive bladder cell lines, revealed significant differential expression of 9 miRNAs. Cell lines characterized as invasive showed a miR-21:miR-205 ratio at least 10-fold higher than the quantitative ratio obtained from non-invasive cell lines. The same expression ratio was determined in 53 bladder tumors. From these results, we recorded a sensitivity and specificity of 100% and 78%, respectively, using a cutoff of 1.79 to predict an invasive lesion. The area under the receiver operator characteristic curve was 0.89. Using in vitro invasion assays, we have demonstrated a role for miR-21 in establishing the invasive phenotype of bladder carcinoma cells.CONCLUSIONIn this study, we identified a miR-21:miR-205 expression ratio that has the ability to distinguish between invasive and noninvasive bladder tumors with high sensitivity and specificity, with the potential to identify superficial lesions at high risk to progress.
Author Rieger-Christ, Kimberly M., Ph.D
Phung, Nu Ai, B.S
McLaughlin, Stephen, Ph.D
Whitney, Duncan, Ph.D
Garver, Joanne, B.S
Neto, Brasil Silva, M.D
Eroshkin, Alexey, Ph.D
Patel, Sonal, B.S
Neely, Lori A., Ph.D
Libertino, John A., M.D
Summerhayes, Ian C., Ph.D
Author_xml – sequence: 1
  fullname: Neely, Lori A., Ph.D
– sequence: 2
  fullname: Rieger-Christ, Kimberly M., Ph.D
– sequence: 3
  fullname: Neto, Brasil Silva, M.D
– sequence: 4
  fullname: Eroshkin, Alexey, Ph.D
– sequence: 5
  fullname: Garver, Joanne, B.S
– sequence: 6
  fullname: Patel, Sonal, B.S
– sequence: 7
  fullname: Phung, Nu Ai, B.S
– sequence: 8
  fullname: McLaughlin, Stephen, Ph.D
– sequence: 9
  fullname: Libertino, John A., M.D
– sequence: 10
  fullname: Whitney, Duncan, Ph.D
– sequence: 11
  fullname: Summerhayes, Ian C., Ph.D
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22313447$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/18799331$$D View this record in MEDLINE/PubMed
BookMark eNqFkcuO1DAQRS00iHnAJ4CyQawSyq8k3oBaI5hBGkDisbbcToVxk9g9dtKi_x5HHYHEhpWt0qkq-9xLcuaDR0KeU6go0Pr1rppjGIK3FQNoK6grgPoRuaBtw0smVH2W79C0JRVcnZPLlHYAVLSUPiHnGVKKc3pBPm6K0dkYvnzaFPhrHzElF3wRzeRC0WHvvPM_iukeC-cPJrkDFvt79GE67pdSsR1M12EspnkMMT0lj3szJHy2nlfk-_t3365vy7vPNx-uN3ellVROpQLZAbIWueK9ErJVSlEle9bUSEGZuhXWSsmpQJBcsVzbUmNawXuGjRX8irw6zd3H8DBjmvToksVhMB7DnHTDBTBZ1zST8kTmP6YUsdf76EYTj5qCXkTqnV5F6kWkhlpnkbnvxbph3o7Y_e1azWXg5QqYZM3QR-OtS384xjIjRJO5tycOs4-Dw6iTdegtdi6inXQX3H-f8uafCXbIseSlP_GIaRfm6LNsTXViGvTXJfUldGhz4DJr_A3J0qlY
CitedBy_id crossref_primary_10_1016_j_urology_2010_03_012
crossref_primary_10_1038_bjc_2015_203
crossref_primary_10_1371_journal_pone_0096670
crossref_primary_10_3892_or_2015_4117
crossref_primary_10_1016_j_urolonc_2009_08_024
crossref_primary_10_4103_UROS_UROS_97_18
crossref_primary_10_1038_s41598_021_86316_w
crossref_primary_10_1007_s40291_019_00410_4
crossref_primary_10_3390_bioengineering8070099
crossref_primary_10_1016_j_ajpath_2012_01_034
crossref_primary_10_1038_bjc_2013_240
crossref_primary_10_1097_MOU_0b013e32834a26cd
crossref_primary_10_1016_j_eururo_2011_01_044
crossref_primary_10_1007_s00109_010_0716_0
crossref_primary_10_3390_ijms141021087
crossref_primary_10_3892_mmr_2015_3769
crossref_primary_10_1007_s00018_013_1275_7
crossref_primary_10_1007_s10059_013_0044_7
crossref_primary_10_1016_j_urolonc_2010_11_007
crossref_primary_10_1074_jbc_M110_198069
crossref_primary_10_1089_dna_2015_2868
crossref_primary_10_1016_j_juro_2012_03_122
crossref_primary_10_1007_s00432_010_0918_4
crossref_primary_10_3892_ol_2015_3540
crossref_primary_10_1007_s00345_012_1010_2
crossref_primary_10_1016_j_vetimm_2013_06_018
crossref_primary_10_3892_mmr_2015_4568
crossref_primary_10_1016_j_prostaglandins_2020_106409
crossref_primary_10_1371_journal_pone_0077853
crossref_primary_10_1007_s00428_013_1518_x
crossref_primary_10_1038_cddis_2015_269
crossref_primary_10_1111_j_1464_410X_2010_09489_x
crossref_primary_10_2478_bjmg_2022_0027
crossref_primary_10_1155_2016_7450461
crossref_primary_10_2217_bmm_14_26
crossref_primary_10_3390_pr9122136
crossref_primary_10_1016_j_canlet_2012_01_027
crossref_primary_10_1002_jcb_28004
crossref_primary_10_2217_bmm_2017_0392
crossref_primary_10_1371_journal_pone_0057490
crossref_primary_10_1371_journal_pone_0018286
crossref_primary_10_7314_APJCP_2013_14_7_4127
crossref_primary_10_1016_j_ejcb_2012_11_002
crossref_primary_10_1007_s13277_015_4698_y
crossref_primary_10_1002_cncr_31062
crossref_primary_10_1002_ijc_27949
crossref_primary_10_3892_mmr_2015_3739
crossref_primary_10_7314_APJCP_2014_15_2_577
crossref_primary_10_1038_onc_2012_300
crossref_primary_10_3390_genes8020077
crossref_primary_10_3390_genes8110339
crossref_primary_10_1038_nrurol_2010_45
crossref_primary_10_18632_oncotarget_15173
crossref_primary_10_1016_j_eururo_2012_11_030
crossref_primary_10_1002_ijc_29413
crossref_primary_10_1371_journal_pone_0039309
crossref_primary_10_1016_j_juro_2012_07_004
crossref_primary_10_1002_cpt_870
crossref_primary_10_4161_epi_25927
crossref_primary_10_1016_j_urolonc_2013_04_014
crossref_primary_10_3892_or_2013_2621
crossref_primary_10_1016_j_jmoldx_2013_05_008
crossref_primary_10_1007_s00432_010_0932_6
crossref_primary_10_1016_j_urolonc_2013_11_001
crossref_primary_10_3892_ol_2017_6746
crossref_primary_10_1186_s12935_014_0070_3
crossref_primary_10_1002_cam4_1161
crossref_primary_10_4103_jcrt_jcrt_1014_21
crossref_primary_10_1111_j_1442_2050_2011_01177_x
Cites_doi 10.1158/1078-0432.CCR-04-2095
10.1038/sj.onc.1209911
10.1038/nature06174
10.1200/JCO.2005.05.5194
10.1038/sj.onc.1207749
10.1158/1078-0432.CCR-05-0259
10.1158/0008-5472.CAN-05-1783
10.1016/j.bbrc.2007.03.201
10.1053/j.gastro.2007.05.022
10.1158/0008-5472.CAN-05-0137
10.1016/j.ccr.2006.04.020
10.1200/JCO.2006.08.2073
10.1109/TVCG.2006.50
10.1158/0008-5472.CAN-03-3620
10.1038/sj.onc.1207274
10.1158/0008-5472.CAN-06-3667
10.1016/j.urolonc.2005.07.011
10.1053/j.gastro.2006.02.057
10.1158/1078-0432.CCR-04-1988
10.1002/ijc.11109
10.1159/000101316
10.1038/nature03702
10.1158/1078-0432.CCR-03-0134
10.1158/1078-0432.CCR-04-2409
10.1016/j.ccr.2006.01.025
10.1038/ng1061
10.1158/1078-0432.CCR-05-0177
10.5507/bp.2006.029
10.1074/jbc.M611393200
10.1038/nmeth825
10.1158/0008-5472.CAN-05-2352
10.1073/pnas.0510565103
10.1038/sj.bjc.6602813
10.1200/JCO.2005.03.2375
10.1038/nrc1840
10.1001/jama.297.17.1901
10.1158/0008-5472.CAN-07-1083
10.1158/0008-5472.CAN-07-0533
10.1158/1078-0432.CCR-06-2330
10.1038/sj.onc.1209913
10.1038/sj.onc.1210083
10.1038/nrc1997
10.1038/nrc1697
ContentType Journal Article
Copyright Elsevier Inc.
2010 Elsevier Inc.
2015 INIST-CNRS
Copyright 2010 Elsevier Inc. All rights reserved.
Copyright_xml – notice: Elsevier Inc.
– notice: 2010 Elsevier Inc.
– notice: 2015 INIST-CNRS
– notice: Copyright 2010 Elsevier Inc. All rights reserved.
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.urolonc.2008.06.006
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1873-2496
EndPage 48
ExternalDocumentID 10_1016_j_urolonc_2008_06_006
18799331
22313447
S1078143908001555
1_s2_0_S1078143908001555
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
-RU
.1-
.FO
.~1
0R~
123
1B1
1P~
1~.
1~5
29Q
4.4
457
4CK
4G.
53G
5RE
5VS
6PF
7-5
71M
8P~
AACTN
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQQT
AAQXK
AAWTL
AAXKI
AAXUO
ABBQC
ABMAC
ABMZM
ABXDB
ACDAQ
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
AEBSH
AEKER
AEVXI
AFJKZ
AFKWA
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJOXV
AJRQY
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HZ~
IHE
J1W
KOM
M41
MO0
N9A
O-L
O9-
OAUVE
OK.
OW.
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SDF
SDG
SEL
SES
SEW
SSH
SSZ
T5K
UDS
UHS
Z5R
ZGI
~G-
AAIAV
ABLVK
ABYKQ
AJBFU
EFLBG
LCYCR
AAPBV
ABPIF
ABPTK
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c515t-905d0e28e393f9458999195f276e109a684cc55314e05392109b1aa843f2e7c43
IEDL.DBID .~1
ISSN 1078-1439
IngestDate Fri Oct 25 06:46:11 EDT 2024
Thu Sep 26 15:57:22 EDT 2024
Sat Sep 28 07:45:53 EDT 2024
Sun Oct 22 16:07:03 EDT 2023
Fri Feb 23 02:13:25 EST 2024
Tue Oct 15 22:55:50 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords microRNAs
Bladder cancer
Single molecule detection
Nephrology
Urinary system disease
RNA interference
Micro RNA
Urinary tract disease
Malignant tumor
Infiltrating tumor
Bladder tumor
Urology
Gene silencing
Molecules
Phenotype
Cancerology
Bladder disease
Ratio
Diagnosis
Cancer
Language English
License CC BY 4.0
Copyright 2010 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c515t-905d0e28e393f9458999195f276e109a684cc55314e05392109b1aa843f2e7c43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 18799331
PQID 734025661
PQPubID 23479
PageCount 10
ParticipantIDs proquest_miscellaneous_734025661
crossref_primary_10_1016_j_urolonc_2008_06_006
pubmed_primary_18799331
pascalfrancis_primary_22313447
elsevier_sciencedirect_doi_10_1016_j_urolonc_2008_06_006
elsevier_clinicalkeyesjournals_1_s2_0_S1078143908001555
PublicationCentury 2000
PublicationDate 2010
2010 Jan-Feb
2010-1-00
20100101
PublicationDateYYYYMMDD 2010-01-01
PublicationDate_xml – year: 2010
  text: 2010
PublicationDecade 2010
PublicationPlace New York, NY
PublicationPlace_xml – name: New York, NY
– name: United States
PublicationTitle Urologic oncology
PublicationTitleAlternate Urol Oncol
PublicationYear 2010
Publisher Elsevier Inc
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Elsevier
References Calin, Croce (bib18) 2006; 6
Sanchez-Carbayo, Socci, Lozano (bib14) 2006; 24
Porkka, Pfeiffer, Waltering (bib25) 2007; 67
Johnson, Esquela-Kerscher, Stefani (bib20) 2007; 67
Saito, Liang, Egger (bib33) 2006; 9
Kusenda, Mraz, Mayer (bib19) 2006; 150
Dyrskjot, Zieger, Kruhoffer (bib13) 2005; 11
Wu (bib1) 2005; 5
Volinia, Calin, Liu (bib29) 2006; 103
Sanchez-Carbayo, Socci, Charytonowicz (bib8) 2002; 62
Takata, Katagiri, Kanehira (bib15) 2005; 11
Ma, Teruya-Feldstein, Weinberg (bib32) 2007; 449
Tran, McLean, Zhang (bib38) 2007; 358
Catto, Xinarianos, Burton (bib42) 2003; 105
Aaboe, Marcussen, Jensen (bib5) 2005; 93
Modlich, Prisack, Pitschke (bib9) 2004; 10
Bloomston, Frankel, Petrocca (bib30) 2007; 297
Mitra, Datar, Cote (bib2) 2006; 24
Lu, Getz, Miska (bib27) 2005; 435
Thykjaer, Workman, Kruhoffer (bib7) 2001; 61
Meng, Henson, Lang (bib34) 2006; 130
Dyrskjot, Thykjaer, Kruhoffer (bib3) 2003; 33
Blaveri, Simko, Korkola (bib12) 2005; 11
Feber, Clark, Goodwin (bib44) 2004; 23
Neely, Patel, Garver (bib37) 2006; 3
Meng, Henson, Wehbe-Janek (bib40) 2007; 133
Oeggerli, Tomovska, Schraml (bib43) 2004; 23
Zhu, Si, Wu (bib41) 2007; 282
Yanaihara, Caplen, Bowman (bib28) 2006; 9
Elsamman, Fukumori, Ewis (bib6) 2006; 24
Wild, Herr, Wissmann (bib10) 2005; 11
Blaveri, Brewer, Roydasgupta (bib11) 2005; 11
Iorio, Ferracin, Liu (bib26) 2005; 65
Dalmay, Edwards (bib39) 2006; 25
Dyrskjot, Kruhoffer, Thykjaer (bib4) 2004; 64
Baumgart, Cohen, Neto (bib46) 2007; 13
Chan, Krichevsky, Kosik (bib21) 2005; 65
Chen, Stallings (bib24) 2007; 67
Kent, Mendell (bib16) 2006; 25
Si, Zhu, Wu (bib23) 2007; 26
Zavadil, Narasimhan, Blumenberg (bib45) 2007; 185
Esquela-Kerscher, Slack (bib17) 2006; 6
Neely, Patel, Garver (bib36) 2006; 3
Seo, Shneiderman (bib35) 2006; 12
Roldo, Missiaglia, Hagan (bib31) 2006; 24
Hayashita, Osada, Tatematsu (bib22) 2005; 65
Aaboe (10.1016/j.urolonc.2008.06.006_bib5) 2005; 93
Sanchez-Carbayo (10.1016/j.urolonc.2008.06.006_bib14) 2006; 24
Chan (10.1016/j.urolonc.2008.06.006_bib21) 2005; 65
Porkka (10.1016/j.urolonc.2008.06.006_bib25) 2007; 67
Mitra (10.1016/j.urolonc.2008.06.006_bib2) 2006; 24
Johnson (10.1016/j.urolonc.2008.06.006_bib20) 2007; 67
Roldo (10.1016/j.urolonc.2008.06.006_bib31) 2006; 24
Yanaihara (10.1016/j.urolonc.2008.06.006_bib28) 2006; 9
Modlich (10.1016/j.urolonc.2008.06.006_bib9) 2004; 10
Bloomston (10.1016/j.urolonc.2008.06.006_bib30) 2007; 297
Hayashita (10.1016/j.urolonc.2008.06.006_bib22) 2005; 65
Blaveri (10.1016/j.urolonc.2008.06.006_bib12) 2005; 11
Kent (10.1016/j.urolonc.2008.06.006_bib16) 2006; 25
Tran (10.1016/j.urolonc.2008.06.006_bib38) 2007; 358
Neely (10.1016/j.urolonc.2008.06.006_bib37) 2006; 3
Esquela-Kerscher (10.1016/j.urolonc.2008.06.006_bib17) 2006; 6
Dyrskjot (10.1016/j.urolonc.2008.06.006_bib3) 2003; 33
Zhu (10.1016/j.urolonc.2008.06.006_bib41) 2007; 282
Dyrskjot (10.1016/j.urolonc.2008.06.006_bib13) 2005; 11
Kusenda (10.1016/j.urolonc.2008.06.006_bib19) 2006; 150
Wild (10.1016/j.urolonc.2008.06.006_bib10) 2005; 11
Iorio (10.1016/j.urolonc.2008.06.006_bib26) 2005; 65
Sanchez-Carbayo (10.1016/j.urolonc.2008.06.006_bib8) 2002; 62
Chen (10.1016/j.urolonc.2008.06.006_bib24) 2007; 67
Neely (10.1016/j.urolonc.2008.06.006_bib36) 2006; 3
Meng (10.1016/j.urolonc.2008.06.006_bib40) 2007; 133
Oeggerli (10.1016/j.urolonc.2008.06.006_bib43) 2004; 23
Wu (10.1016/j.urolonc.2008.06.006_bib1) 2005; 5
Thykjaer (10.1016/j.urolonc.2008.06.006_bib7) 2001; 61
Dyrskjot (10.1016/j.urolonc.2008.06.006_bib4) 2004; 64
Feber (10.1016/j.urolonc.2008.06.006_bib44) 2004; 23
Zavadil (10.1016/j.urolonc.2008.06.006_bib45) 2007; 185
Seo (10.1016/j.urolonc.2008.06.006_bib35) 2006; 12
Lu (10.1016/j.urolonc.2008.06.006_bib27) 2005; 435
Calin (10.1016/j.urolonc.2008.06.006_bib18) 2006; 6
Si (10.1016/j.urolonc.2008.06.006_bib23) 2007; 26
Meng (10.1016/j.urolonc.2008.06.006_bib34) 2006; 130
Takata (10.1016/j.urolonc.2008.06.006_bib15) 2005; 11
Dalmay (10.1016/j.urolonc.2008.06.006_bib39) 2006; 25
Baumgart (10.1016/j.urolonc.2008.06.006_bib46) 2007; 13
Elsamman (10.1016/j.urolonc.2008.06.006_bib6) 2006; 24
Saito (10.1016/j.urolonc.2008.06.006_bib33) 2006; 9
Catto (10.1016/j.urolonc.2008.06.006_bib42) 2003; 105
Blaveri (10.1016/j.urolonc.2008.06.006_bib11) 2005; 11
Volinia (10.1016/j.urolonc.2008.06.006_bib29) 2006; 103
Ma (10.1016/j.urolonc.2008.06.006_bib32) 2007; 449
References_xml – volume: 33
  start-page: 90
  year: 2003
  end-page: 96
  ident: bib3
  article-title: Identifying distinct classes of bladder carcinoma using microarrays
  publication-title: Nat Genet
  contributor:
    fullname: Kruhoffer
– volume: 5
  start-page: 713
  year: 2005
  end-page: 725
  ident: bib1
  article-title: Urothelial tumorigenesis: A tale of divergent pathways
  publication-title: Nat Rev Cancer
  contributor:
    fullname: Wu
– volume: 24
  start-page: 4677
  year: 2006
  end-page: 4684
  ident: bib31
  article-title: MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior
  publication-title: J Clin Oncol
  contributor:
    fullname: Hagan
– volume: 24
  start-page: 109
  year: 2006
  end-page: 115
  ident: bib6
  article-title: Differences in gene expression between noninvasive and invasive transitional cell carcinoma of the human bladder using complementary deoxyribonucleic acid microarray: Preliminary results
  publication-title: Urol Oncol
  contributor:
    fullname: Ewis
– volume: 10
  start-page: 3410
  year: 2004
  end-page: 3421
  ident: bib9
  article-title: Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: Use of cDNA array analysis of gene expression profiles
  publication-title: Clin Cancer Res
  contributor:
    fullname: Pitschke
– volume: 65
  start-page: 9628
  year: 2005
  end-page: 9632
  ident: bib22
  article-title: A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation
  publication-title: Cancer Res
  contributor:
    fullname: Tatematsu
– volume: 65
  start-page: 7065
  year: 2005
  end-page: 7070
  ident: bib26
  article-title: MicroRNA gene expression deregulation in human breast cancer
  publication-title: Cancer Res
  contributor:
    fullname: Liu
– volume: 435
  start-page: 834
  year: 2005
  end-page: 838
  ident: bib27
  article-title: MicroRNA expression profiles classify human cancers
  publication-title: Nature
  contributor:
    fullname: Miska
– volume: 9
  start-page: 189
  year: 2006
  end-page: 198
  ident: bib28
  article-title: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
  publication-title: Cancer Cell
  contributor:
    fullname: Bowman
– volume: 11
  start-page: 4044
  year: 2005
  end-page: 4055
  ident: bib12
  article-title: Bladder cancer outcome and subtype classification by gene expression
  publication-title: Clin Cancer Res
  contributor:
    fullname: Korkola
– volume: 65
  start-page: 6029
  year: 2005
  end-page: 6033
  ident: bib21
  article-title: MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells
  publication-title: Cancer Res
  contributor:
    fullname: Kosik
– volume: 67
  start-page: 6130
  year: 2007
  end-page: 6135
  ident: bib25
  article-title: MicroRNA expression profiling in prostate cancer
  publication-title: Cancer Res
  contributor:
    fullname: Waltering
– volume: 297
  start-page: 1901
  year: 2007
  end-page: 1908
  ident: bib30
  article-title: MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis
  publication-title: JAMA
  contributor:
    fullname: Petrocca
– volume: 449
  start-page: 682
  year: 2007
  end-page: 688
  ident: bib32
  article-title: Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
  publication-title: Nature
  contributor:
    fullname: Weinberg
– volume: 103
  start-page: 2257
  year: 2006
  end-page: 2261
  ident: bib29
  article-title: A microRNA expression signature of human solid tumors defines cancer gene targets
  publication-title: Proc Natl Acad Sci U S A
  contributor:
    fullname: Liu
– volume: 3
  start-page: 41
  year: 2006
  end-page: 46
  ident: bib37
  article-title: A single-molecule method for the quantitation of microRNA gene expression
  publication-title: Nat Methods
  contributor:
    fullname: Garver
– volume: 64
  start-page: 4040
  year: 2004
  end-page: 4048
  ident: bib4
  article-title: Gene expression in the urinary bladder: A common carcinoma in situ gene expression signature exists disregarding histopathological classification
  publication-title: Cancer Res
  contributor:
    fullname: Thykjaer
– volume: 3
  start-page: 41
  year: 2006
  end-page: 46
  ident: bib36
  article-title: A single-molecule method for the quantitation of microRNA gene expression
  publication-title: Nat Methods
  contributor:
    fullname: Garver
– volume: 12
  start-page: 311
  year: 2006
  end-page: 322
  ident: bib35
  article-title: Knowledge discovery in high-dimensional data: Case studies and a user survey for the rank-by-feature framework
  publication-title: IEEE Trans Vis Comput Graph
  contributor:
    fullname: Shneiderman
– volume: 358
  start-page: 12
  year: 2007
  end-page: 17
  ident: bib38
  article-title: MicroRNA expression profiles in head and neck cancer cell lines
  publication-title: Biochem Biophys Res Commun
  contributor:
    fullname: Zhang
– volume: 105
  start-page: 484
  year: 2003
  end-page: 490
  ident: bib42
  article-title: Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability
  publication-title: Int J Cancer
  contributor:
    fullname: Burton
– volume: 67
  start-page: 7713
  year: 2007
  end-page: 7722
  ident: bib20
  article-title: The let-7 microRNA represses cell proliferation pathways in human cells
  publication-title: Cancer Res
  contributor:
    fullname: Stefani
– volume: 23
  start-page: 5616
  year: 2004
  end-page: 5623
  ident: bib43
  article-title: E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer
  publication-title: Oncogene
  contributor:
    fullname: Schraml
– volume: 23
  start-page: 1627
  year: 2004
  end-page: 1630
  ident: bib44
  article-title: Amplification and overexpression of E2F3 in human bladder cancer
  publication-title: Oncogene
  contributor:
    fullname: Goodwin
– volume: 11
  start-page: 4029
  year: 2005
  end-page: 4036
  ident: bib13
  article-title: A molecular signature in superficial bladder carcinoma predicts clinical outcome
  publication-title: Clin Cancer Res
  contributor:
    fullname: Kruhoffer
– volume: 6
  start-page: 857
  year: 2006
  end-page: 866
  ident: bib18
  article-title: MicroRNA signatures in human cancers
  publication-title: Nat Rev Cancer
  contributor:
    fullname: Croce
– volume: 11
  start-page: 7012
  year: 2005
  end-page: 7022
  ident: bib11
  article-title: Bladder cancer stage and outcome by array-based comparative genomic hybridization
  publication-title: Clin Cancer Res
  contributor:
    fullname: Roydasgupta
– volume: 133
  start-page: 647
  year: 2007
  end-page: 658
  ident: bib40
  article-title: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer
  publication-title: Gastroenterology
  contributor:
    fullname: Wehbe-Janek
– volume: 185
  start-page: 157
  year: 2007
  end-page: 161
  ident: bib45
  article-title: Transforming growth factor-beta and microRNA:mRNA regulatory networks in epithelial plasticity
  publication-title: Cells Tissues Organs
  contributor:
    fullname: Blumenberg
– volume: 130
  start-page: 2113
  year: 2006
  end-page: 2129
  ident: bib34
  article-title: Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines
  publication-title: Gastroenterology
  contributor:
    fullname: Lang
– volume: 6
  start-page: 259
  year: 2006
  end-page: 269
  ident: bib17
  article-title: Oncomirs-microRNAs with a role in cancer
  publication-title: Nat Rev Cancer
  contributor:
    fullname: Slack
– volume: 25
  start-page: 6170
  year: 2006
  end-page: 6175
  ident: bib39
  article-title: MicroRNAs and the hallmarks of cancer
  publication-title: Oncogene
  contributor:
    fullname: Edwards
– volume: 25
  start-page: 6188
  year: 2006
  end-page: 6196
  ident: bib16
  article-title: A small piece in the cancer puzzle: MicroRNAs as tumor suppressors and oncogenes
  publication-title: Oncogene
  contributor:
    fullname: Mendell
– volume: 61
  start-page: 2492
  year: 2001
  end-page: 2499
  ident: bib7
  article-title: Identification of gene expression patterns in superficial and invasive human bladder cancer
  publication-title: Cancer Res
  contributor:
    fullname: Kruhoffer
– volume: 11
  start-page: 4415
  year: 2005
  end-page: 4429
  ident: bib10
  article-title: Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder
  publication-title: Clin Cancer Res
  contributor:
    fullname: Wissmann
– volume: 67
  start-page: 976
  year: 2007
  end-page: 983
  ident: bib24
  article-title: Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis
  publication-title: Cancer Res
  contributor:
    fullname: Stallings
– volume: 93
  start-page: 1182
  year: 2005
  end-page: 1190
  ident: bib5
  article-title: Gene expression profiling of noninvasive primary urothelial tumours using microarrays
  publication-title: Br J Cancer
  contributor:
    fullname: Jensen
– volume: 62
  start-page: 6973
  year: 2002
  end-page: 6980
  ident: bib8
  article-title: Molecular profiling of bladder cancer using cDNA microarrays: Defining histogenesis and biological phenotypes
  publication-title: Cancer Res
  contributor:
    fullname: Charytonowicz
– volume: 24
  start-page: 5552
  year: 2006
  end-page: 5564
  ident: bib2
  article-title: Molecular pathways in invasive bladder cancer: New insights into mechanisms, progression, and target identification
  publication-title: J Clin Oncol
  contributor:
    fullname: Cote
– volume: 11
  start-page: 2625
  year: 2005
  end-page: 2636
  ident: bib15
  article-title: Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling
  publication-title: Clin Cancer Res
  contributor:
    fullname: Kanehira
– volume: 13
  start-page: 1685
  year: 2007
  end-page: 1694
  ident: bib46
  article-title: Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors
  publication-title: Clin Cancer Res
  contributor:
    fullname: Neto
– volume: 26
  start-page: 2799
  year: 2007
  end-page: 2803
  ident: bib23
  article-title: miR-21-mediated tumor growth
  publication-title: Oncogene
  contributor:
    fullname: Wu
– volume: 150
  start-page: 205
  year: 2006
  end-page: 215
  ident: bib19
  article-title: MicroRNA biogenesis, functionality and cancer relevance
  publication-title: Biomed Pap Med Fac Univ Palacky Olomouc Czecho Repub
  contributor:
    fullname: Mayer
– volume: 282
  start-page: 14328
  year: 2007
  end-page: 14336
  ident: bib41
  article-title: MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1)
  publication-title: Journal Biol Chem
  contributor:
    fullname: Wu
– volume: 24
  start-page: 778
  year: 2006
  end-page: 789
  ident: bib14
  article-title: Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays
  publication-title: J Clin Oncol
  contributor:
    fullname: Lozano
– volume: 9
  start-page: 435
  year: 2006
  end-page: 443
  ident: bib33
  article-title: Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells
  publication-title: Cancer Cell
  contributor:
    fullname: Egger
– volume: 11
  start-page: 4029
  year: 2005
  ident: 10.1016/j.urolonc.2008.06.006_bib13
  article-title: A molecular signature in superficial bladder carcinoma predicts clinical outcome
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-04-2095
  contributor:
    fullname: Dyrskjot
– volume: 25
  start-page: 6170
  year: 2006
  ident: 10.1016/j.urolonc.2008.06.006_bib39
  article-title: MicroRNAs and the hallmarks of cancer
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1209911
  contributor:
    fullname: Dalmay
– volume: 449
  start-page: 682
  year: 2007
  ident: 10.1016/j.urolonc.2008.06.006_bib32
  article-title: Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
  publication-title: Nature
  doi: 10.1038/nature06174
  contributor:
    fullname: Ma
– volume: 24
  start-page: 4677
  year: 2006
  ident: 10.1016/j.urolonc.2008.06.006_bib31
  article-title: MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2005.05.5194
  contributor:
    fullname: Roldo
– volume: 23
  start-page: 5616
  year: 2004
  ident: 10.1016/j.urolonc.2008.06.006_bib43
  article-title: E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1207749
  contributor:
    fullname: Oeggerli
– volume: 11
  start-page: 4415
  year: 2005
  ident: 10.1016/j.urolonc.2008.06.006_bib10
  article-title: Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-05-0259
  contributor:
    fullname: Wild
– volume: 65
  start-page: 7065
  year: 2005
  ident: 10.1016/j.urolonc.2008.06.006_bib26
  article-title: MicroRNA gene expression deregulation in human breast cancer
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-05-1783
  contributor:
    fullname: Iorio
– volume: 358
  start-page: 12
  year: 2007
  ident: 10.1016/j.urolonc.2008.06.006_bib38
  article-title: MicroRNA expression profiles in head and neck cancer cell lines
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2007.03.201
  contributor:
    fullname: Tran
– volume: 133
  start-page: 647
  year: 2007
  ident: 10.1016/j.urolonc.2008.06.006_bib40
  article-title: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2007.05.022
  contributor:
    fullname: Meng
– volume: 65
  start-page: 6029
  year: 2005
  ident: 10.1016/j.urolonc.2008.06.006_bib21
  article-title: MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-05-0137
  contributor:
    fullname: Chan
– volume: 9
  start-page: 435
  year: 2006
  ident: 10.1016/j.urolonc.2008.06.006_bib33
  article-title: Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2006.04.020
  contributor:
    fullname: Saito
– volume: 24
  start-page: 5552
  year: 2006
  ident: 10.1016/j.urolonc.2008.06.006_bib2
  article-title: Molecular pathways in invasive bladder cancer: New insights into mechanisms, progression, and target identification
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2006.08.2073
  contributor:
    fullname: Mitra
– volume: 12
  start-page: 311
  year: 2006
  ident: 10.1016/j.urolonc.2008.06.006_bib35
  article-title: Knowledge discovery in high-dimensional data: Case studies and a user survey for the rank-by-feature framework
  publication-title: IEEE Trans Vis Comput Graph
  doi: 10.1109/TVCG.2006.50
  contributor:
    fullname: Seo
– volume: 64
  start-page: 4040
  year: 2004
  ident: 10.1016/j.urolonc.2008.06.006_bib4
  article-title: Gene expression in the urinary bladder: A common carcinoma in situ gene expression signature exists disregarding histopathological classification
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-03-3620
  contributor:
    fullname: Dyrskjot
– volume: 23
  start-page: 1627
  year: 2004
  ident: 10.1016/j.urolonc.2008.06.006_bib44
  article-title: Amplification and overexpression of E2F3 in human bladder cancer
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1207274
  contributor:
    fullname: Feber
– volume: 67
  start-page: 976
  year: 2007
  ident: 10.1016/j.urolonc.2008.06.006_bib24
  article-title: Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-06-3667
  contributor:
    fullname: Chen
– volume: 62
  start-page: 6973
  year: 2002
  ident: 10.1016/j.urolonc.2008.06.006_bib8
  article-title: Molecular profiling of bladder cancer using cDNA microarrays: Defining histogenesis and biological phenotypes
  publication-title: Cancer Res
  contributor:
    fullname: Sanchez-Carbayo
– volume: 24
  start-page: 109
  year: 2006
  ident: 10.1016/j.urolonc.2008.06.006_bib6
  article-title: Differences in gene expression between noninvasive and invasive transitional cell carcinoma of the human bladder using complementary deoxyribonucleic acid microarray: Preliminary results
  publication-title: Urol Oncol
  doi: 10.1016/j.urolonc.2005.07.011
  contributor:
    fullname: Elsamman
– volume: 130
  start-page: 2113
  year: 2006
  ident: 10.1016/j.urolonc.2008.06.006_bib34
  article-title: Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2006.02.057
  contributor:
    fullname: Meng
– volume: 11
  start-page: 2625
  year: 2005
  ident: 10.1016/j.urolonc.2008.06.006_bib15
  article-title: Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-04-1988
  contributor:
    fullname: Takata
– volume: 105
  start-page: 484
  year: 2003
  ident: 10.1016/j.urolonc.2008.06.006_bib42
  article-title: Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability
  publication-title: Int J Cancer
  doi: 10.1002/ijc.11109
  contributor:
    fullname: Catto
– volume: 185
  start-page: 157
  year: 2007
  ident: 10.1016/j.urolonc.2008.06.006_bib45
  article-title: Transforming growth factor-beta and microRNA:mRNA regulatory networks in epithelial plasticity
  publication-title: Cells Tissues Organs
  doi: 10.1159/000101316
  contributor:
    fullname: Zavadil
– volume: 435
  start-page: 834
  year: 2005
  ident: 10.1016/j.urolonc.2008.06.006_bib27
  article-title: MicroRNA expression profiles classify human cancers
  publication-title: Nature
  doi: 10.1038/nature03702
  contributor:
    fullname: Lu
– volume: 10
  start-page: 3410
  year: 2004
  ident: 10.1016/j.urolonc.2008.06.006_bib9
  article-title: Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: Use of cDNA array analysis of gene expression profiles
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-03-0134
  contributor:
    fullname: Modlich
– volume: 11
  start-page: 4044
  year: 2005
  ident: 10.1016/j.urolonc.2008.06.006_bib12
  article-title: Bladder cancer outcome and subtype classification by gene expression
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-04-2409
  contributor:
    fullname: Blaveri
– volume: 9
  start-page: 189
  year: 2006
  ident: 10.1016/j.urolonc.2008.06.006_bib28
  article-title: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2006.01.025
  contributor:
    fullname: Yanaihara
– volume: 33
  start-page: 90
  year: 2003
  ident: 10.1016/j.urolonc.2008.06.006_bib3
  article-title: Identifying distinct classes of bladder carcinoma using microarrays
  publication-title: Nat Genet
  doi: 10.1038/ng1061
  contributor:
    fullname: Dyrskjot
– volume: 11
  start-page: 7012
  year: 2005
  ident: 10.1016/j.urolonc.2008.06.006_bib11
  article-title: Bladder cancer stage and outcome by array-based comparative genomic hybridization
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-05-0177
  contributor:
    fullname: Blaveri
– volume: 150
  start-page: 205
  year: 2006
  ident: 10.1016/j.urolonc.2008.06.006_bib19
  article-title: MicroRNA biogenesis, functionality and cancer relevance
  publication-title: Biomed Pap Med Fac Univ Palacky Olomouc Czecho Repub
  doi: 10.5507/bp.2006.029
  contributor:
    fullname: Kusenda
– volume: 282
  start-page: 14328
  year: 2007
  ident: 10.1016/j.urolonc.2008.06.006_bib41
  article-title: MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1)
  publication-title: Journal Biol Chem
  doi: 10.1074/jbc.M611393200
  contributor:
    fullname: Zhu
– volume: 3
  start-page: 41
  year: 2006
  ident: 10.1016/j.urolonc.2008.06.006_bib36
  article-title: A single-molecule method for the quantitation of microRNA gene expression
  publication-title: Nat Methods
  doi: 10.1038/nmeth825
  contributor:
    fullname: Neely
– volume: 65
  start-page: 9628
  year: 2005
  ident: 10.1016/j.urolonc.2008.06.006_bib22
  article-title: A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-05-2352
  contributor:
    fullname: Hayashita
– volume: 103
  start-page: 2257
  year: 2006
  ident: 10.1016/j.urolonc.2008.06.006_bib29
  article-title: A microRNA expression signature of human solid tumors defines cancer gene targets
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0510565103
  contributor:
    fullname: Volinia
– volume: 3
  start-page: 41
  year: 2006
  ident: 10.1016/j.urolonc.2008.06.006_bib37
  article-title: A single-molecule method for the quantitation of microRNA gene expression
  publication-title: Nat Methods
  doi: 10.1038/nmeth825
  contributor:
    fullname: Neely
– volume: 93
  start-page: 1182
  year: 2005
  ident: 10.1016/j.urolonc.2008.06.006_bib5
  article-title: Gene expression profiling of noninvasive primary urothelial tumours using microarrays
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6602813
  contributor:
    fullname: Aaboe
– volume: 24
  start-page: 778
  year: 2006
  ident: 10.1016/j.urolonc.2008.06.006_bib14
  article-title: Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2005.03.2375
  contributor:
    fullname: Sanchez-Carbayo
– volume: 61
  start-page: 2492
  year: 2001
  ident: 10.1016/j.urolonc.2008.06.006_bib7
  article-title: Identification of gene expression patterns in superficial and invasive human bladder cancer
  publication-title: Cancer Res
  contributor:
    fullname: Thykjaer
– volume: 6
  start-page: 259
  year: 2006
  ident: 10.1016/j.urolonc.2008.06.006_bib17
  article-title: Oncomirs-microRNAs with a role in cancer
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc1840
  contributor:
    fullname: Esquela-Kerscher
– volume: 297
  start-page: 1901
  year: 2007
  ident: 10.1016/j.urolonc.2008.06.006_bib30
  article-title: MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis
  publication-title: JAMA
  doi: 10.1001/jama.297.17.1901
  contributor:
    fullname: Bloomston
– volume: 67
  start-page: 7713
  year: 2007
  ident: 10.1016/j.urolonc.2008.06.006_bib20
  article-title: The let-7 microRNA represses cell proliferation pathways in human cells
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-07-1083
  contributor:
    fullname: Johnson
– volume: 67
  start-page: 6130
  year: 2007
  ident: 10.1016/j.urolonc.2008.06.006_bib25
  article-title: MicroRNA expression profiling in prostate cancer
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-07-0533
  contributor:
    fullname: Porkka
– volume: 13
  start-page: 1685
  year: 2007
  ident: 10.1016/j.urolonc.2008.06.006_bib46
  article-title: Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-06-2330
  contributor:
    fullname: Baumgart
– volume: 25
  start-page: 6188
  year: 2006
  ident: 10.1016/j.urolonc.2008.06.006_bib16
  article-title: A small piece in the cancer puzzle: MicroRNAs as tumor suppressors and oncogenes
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1209913
  contributor:
    fullname: Kent
– volume: 26
  start-page: 2799
  year: 2007
  ident: 10.1016/j.urolonc.2008.06.006_bib23
  article-title: miR-21-mediated tumor growth
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1210083
  contributor:
    fullname: Si
– volume: 6
  start-page: 857
  year: 2006
  ident: 10.1016/j.urolonc.2008.06.006_bib18
  article-title: MicroRNA signatures in human cancers
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc1997
  contributor:
    fullname: Calin
– volume: 5
  start-page: 713
  year: 2005
  ident: 10.1016/j.urolonc.2008.06.006_bib1
  article-title: Urothelial tumorigenesis: A tale of divergent pathways
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc1697
  contributor:
    fullname: Wu
SSID ssj0014811
Score 2.237413
Snippet Abstract Objective The goal of this study was to identify a microRNA (miRNA) signature in bladder cancer capable of differentiating superficial from invasive...
The goal of this study was to identify a microRNA (miRNA) signature in bladder cancer capable of differentiating superficial from invasive disease. Expression...
OBJECTIVEThe goal of this study was to identify a microRNA (miRNA) signature in bladder cancer capable of differentiating superficial from invasive...
SourceID proquest
crossref
pubmed
pascalfrancis
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 39
SubjectTerms Aged
Biological and medical sciences
Bladder cancer
Cell Line, Tumor
Female
Humans
Male
Medical sciences
microRNAs
MicroRNAs - biosynthesis
Neoplasm Invasiveness
Nephrology. Urinary tract diseases
Phenotype
Single molecule detection
Tumor Cells, Cultured
Tumors
Tumors of the urinary system
Urinary Bladder Neoplasms - genetics
Urinary Bladder Neoplasms - pathology
Urinary tract. Prostate gland
Urology
Title A microRNA expression ratio defining the invasive phenotype in bladder tumors
URI https://www.clinicalkey.es/playcontent/1-s2.0-S1078143908001555
https://dx.doi.org/10.1016/j.urolonc.2008.06.006
https://www.ncbi.nlm.nih.gov/pubmed/18799331
https://search.proquest.com/docview/734025661
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dSyMxEB_EAxFE7vxc7yx58HXbTZPsx2ORk3rSPvgBvoV0N4GKbku3FZ_8253ZzVbkEMHXkCXZmWTml8xvMgBneWwcz5UKk8JOQsmjKDSFLMJC4V7CA4dL6lDMaBwP7-S_e3W_AedtLgzRKr3tb2x6ba19S89LszefTns3nN6pQX9KmAe9IiWaS3R_uKa7r2uaB6L9ugYvdQ6p93sWT--hu1qghSlzT6mksET8mX_amZsKpeaachef49HaL138hF0PKNmgmfMv2LDlHmyNfMh8H0YD9kSku-vxgNkXT3stWa14VlhXF4hgCAPZtHw2RGZnRPua0d0sNrHJI9mmBVuunmaL6gDuLv7eng9DX0MhzBGpLMMsUkVk-6kVmXCZVCkBwky5fhJbHmUmTmWOqhJcUo2IDA-A2YQbk0rh-jbJpTiEzXJW2mNgDqFA5CIhMmXx1GkNgp9CmNQItJqFSgLotpLT8-apDN1yyB60F7Uve0lcujiApJWvbvNA0XLZym-jSnNd9XWk_1N1AOn6yw-rRaMj-GrQzgdNrqeKOInT84cBsFa1GrcaxU9MaWerSidCEkKMeQBHjcrf_zNNEOgJfvL9if2G7YaZQNc7f2BzuVjZUwQ8y0mnXtEd-DG4vBqO3wDE1f3z
link.rule.ids 315,783,787,4031,4509,24128,27935,27936,27937,45597,45691
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fT9swED4BkwBpmsaPjWwM_MBr2ri28-OxQkPdRvuwgcSb5Sa21ArSqmkRT_zt3CVOEZoQEq-Wozh39nefc599AGd5bBzPlQqTwo5DyaMoNIUswkLhWsINh0vqVMxwFA-u5e8bdbMB5-1ZGJJVeuxvML1Ga9_S9dbszieT7j9O99RgPCXOg1FRbcIHSfwYJ3Xnca3zQLpfF-Gl3iF1fz7G0512VguEmDL3mkrKS8SvBaiPc1Oh2VxT7-J1QloHpovP8MkzStZvBr0HG7bch-2hz5kfwLDP7kh193fUZ_bB615LVnueFdbVFSIY8kA2Ke8NqdkZ6b5m9HMWm9j4lsBpwZaru9miOoTri59X54PQF1EIc6QqyzCLVBHZXmpFJlwmVUqMMFOul8SWR5mJU5mjrwSXVCQiwx1gNubGpFK4nk1yKb7AVjkr7REwh1wgcpEQmbK47bQG2U8hTGoEwmahkgA6reX0vLkrQ7cisqn2pvZ1L0lMFweQtPbV7UFQhC5b-XVUaa6rno70f74OIF0_-WK6aIwEb7305IUn10NFosTp_sMAWOtajWuNEiimtLNVpRMhiSLGPICvjcufvzNNkOkJ_u39AzuFncHV8FJf_hr9-Q67jUyB_vUcw9ZysbI_kP0sxyf17H4Cp93_jA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+microRNA+expression+ratio+defining+the+invasive+phenotype+in+bladder+tumors&rft.jtitle=Urologic+oncology&rft.au=Neely%2C+Lori+A.%2C+Ph.D&rft.au=Rieger-Christ%2C+Kimberly+M.%2C+Ph.D&rft.au=Neto%2C+Brasil+Silva%2C+M.D&rft.au=Eroshkin%2C+Alexey%2C+Ph.D&rft.date=2010&rft.issn=1078-1439&rft.volume=28&rft.issue=1&rft.spage=39&rft.epage=48&rft_id=info:doi/10.1016%2Fj.urolonc.2008.06.006&rft.externalDBID=ECK1-s2.0-S1078143908001555&rft.externalDocID=1_s2_0_S1078143908001555
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F10781439%2FS1078143909X00074%2Fcov150h.gif